Dexcom (DXCM) Debt Ratio (2010 - 2025)

Dexcom's (DXCM) quarterly Debt Ratio came in at 0.16 in Q3 2025, down 2.24% quarter-over-quarter from 0.16 in Q2 2025.

Analysis

Dexcom (DXCM) Debt Ratio (2010 - 2025) Analysis & Trends

Dexcom (DXCM) has reported Debt Ratio for 12 consecutive years, with 0.16 the latest figure, recorded in Q3 2025.

On a quarterly basis, Debt Ratio changed N/A year-over-year to 0.16 in Q3 2025; TTM through Sep 2025 was 0.16, a N/A change from a year earlier, with the FY2024 full-year figure at 0.19, changed N/A from the prior year.
Debt Ratio was 0.16 for Q3 2025 at Dexcom, down from 0.16 in the prior quarter.
Over five years, Debt Ratio peaked at 0.19 in Q4 2024 and troughed at 0.02 in Q3 2023.
A 4-year average of 0.14 and a median of 0.15 in 2025 frame the typical range for Debt Ratio.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Abbott Laboratories	183.04 Bn	177.44 Bn	7.27 Bn	0.30
2	Intuitive Surgical	125.02 Bn	119.81 Bn	1.96 Bn	-
3	Medtronic	117.84 Bn	109.02 Bn	6.34 Bn	0.30
4	Stryker	105.50 Bn	102.02 Bn	4.50 Bn	0.31
5	Boston Scientific	66.27 Bn	65.73 Bn	3.85 Bn	0.28
6	Edwards Lifesciences	49.60 Bn	45.35 Bn	1.35 Bn	0.04
7	Alcon	33.70 Bn	32.24 Bn	1.68 Bn	0.13
8	Dexcom	32.06 Bn	30.11 Bn	830.00 Mn	-
9	Steris	21.02 Bn	20.54 Bn	684.20 Mn	0.20
10	Zimmer Biomet Holdings	18.20 Bn	17.79 Bn	1.54 Bn	0.33

Historic Data

Download Data